62
2
8
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T2355 | CFTR(inh)-172 | CFTRinh 172,CFTR Inhibitor-172,CFTRinh-172,CFTRinh172 | CFTR , Autophagy |
CFTR(inh)-172 (CFTR Inhibitor-172) is a voltage-independent, selective CFTR inhibitor. | |||
T10776 | CFTR corrector 4 | CFTR | |
CFTR corrector 4 is a potent and orally available transmembrane conductance regulator (CFTR) for cystic fibrosis and is a potent (R,R) type active enantiomer. CFTR corrector 4 increases CFTR levels on the cell surface a... | |||
T5312 | CFTR corrector 2 | FDL169 | CFTR , Autophagy |
CFTR corrector 2 (FDL169) is a novel and potent CFTR (Cystic fibrosis transmembrane conductance regulator) corrector for treating cystic fibrosis (CF) patients who carry the F508del mutation. | |||
T63806 | CFTR corrector 8 | CFTR | |
CFTR corrector 8 is a highly effective modulator of the cystic fibrosis transmembrane conductance regulator (CFTR). This compound is specifically designed for utilization in research related to cystic fibrosis, a genetic... | |||
T60653 | CFTR corrector 9 | CFTR | |
CFTR Corrector 9, a cystic fibrosis transmembrane conductance regulator (CFTR) modulator, is employed in the research of cystic fibrosis (CF) and related CFTR-associated disorders [1]. | |||
T1874 | PPQ-102 | PPQ102,CFTR Inhibitor,PPQ 102 | CFTR , Autophagy |
PPQ-102 (CFTR Inhibitor), an effective CFTR inhibitor, can completely inhibit CFTR chloride current (IC50: 90 nM). | |||
T37686 | CFTR corrector 6 | ||
CFTR corrector 6 is a highly effective CFTR potentiator utilized in research on cystic fibrosis (CF) and related CFTR-associated disorders[1]. This potent compound exhibits potentiation activity on the Cystic Fibrosis Tr... | |||
T79578 | CFTR corrector 12 | CFTR | |
CFTR Corrector 12 (Compound 17C), a bithiazole derivative, functions as a CFTR corrector by remedying certain folding-defective mutants of the channel that regulates chloride transport across the plasma membrane. Additio... | |||
T2451 | GlyH-101 | GlyH 101 | CFTR , Autophagy |
GlyH-101 is a cell-permeable glycinyl hydrazone compound that blocks CFTR with Ki of 1.4 uM. | |||
T3135 | KM11060 | CFTR , Autophagy | |
KM11060 is a novel corrector of the F508del-CFTR trafficking defect, Correcting F508del-CFTR trafficking, increasing the amount of functional CFTR at the plasma membrane. | |||
T1805 | Ataluren | PTC124 | CFTR , Autophagy |
Ataluren (PTC124) is a novel, orally administered drug that targets nonsense mutations. Ataluren is approved for use by the European Medicines Agency to treat Duchenne Muscular Dystrophy in patients aged 5 years and olde... | |||
T9499 | Icenticaftor | QBW251 | CFTR |
Icenticaftor (QBW251) is an orally active potentiator of CFTR channel. | |||
T14935 | Elexacaftor | VX-445 | CFTR , Autophagy |
Elexacaftor (VX-445) is a modulator of cystic fibrosis transmembrane conductance regulator (CFTR) and it also facilitates the processing and trafficking of CFTR to increase the amount of CFTR at the cell surface. | |||
T16681 | Nesolicaftor | PTI-428 | CFTR , Autophagy |
Nesolicaftor (PTI-428) specifically enhances cystic fibrosis transmembrane conductance regulator protein synthesis. | |||
T2588 | Ivacaftor | Ivacaftor (VX-770),VX-770 | CFTR , Autophagy |
Ivacaftor (VX-770) (VX-770) is a potentiator of CFTR targeting G551D-CFTR (EC50: 100 nM) and F508del-CFTR (EC50: 25 nM) in Fisher rat thyroid cells, respectively. | |||
T10591 | BPO-27 racemate | BPO-27 (racemate) | CFTR , Autophagy |
BPO-27 racemate (BPO-27 (racemate)) is an effective CFTR inhibitor with IC50 of 8 nM. | |||
T2486 | IOWH-032 | IOWH032,IOWH 032 | CFTR , Autophagy |
IOWH-032 (IOWH032) , a synthetic CFTR inhibitor, has been investigated for the treatment of cholera, diarrhea, and secretory diarrhea. | |||
T7083 | GLPG1837 | ABBV-974 | CFTR , Autophagy |
GLPG1837 (ABBV-974) is an effective CFTR potentiator, with EC50s of 3 nM and 339 nM for F508del and G551D CFTR, respectively. | |||
T2595 | Lumacaftor | VX-809,VRT 826809 | CFTR , Autophagy |
Lumacaftor (VRT 826809) is a CFTR modulator that corrects the folding and trafficking of CFTR protein. It enhances F508del-CFTR protein maturation in FRT cells (EC50: 100 nM). | |||
T1634 | Glibenclamide | Glyburide | Potassium Channel , Mitochondrial Metabolism , CFTR , P-gp , Autophagy |
Glibenclamide (Glyburide) is an antidiabetic sulfonylurea derivative with actions similar to those of chlorpropamide. | |||
T2263 | Tezacaftor | VX661 | CFTR , Autophagy |
Tezacaftor (VX661) is a small molecule that can be used as a corrector of the cystic fibrosis transmembrane conductance regulator (CFTR) gene function. | |||
T16516 | PG01 | Phenylglycine-01 | CFTR |
PG01 is a potent CFTR Cl-channel potentiator, effective against ΔF508 (Ka 0.3 μM), and also against E193K, G970R and G551D (CFTR mutants), with Kd values of 0.22 μM, 0.45 μM and 1.94 μM, respectively.PG01 increases ΔF508... | |||
T10591L | (R)-BPO-27 | CFTR , Autophagy | |
(R)-BPO-27 is an orally active and potent ATP-competitive CFTR inhibitor (IC50: 4 nM) for the study of diarrhoea and polycystic kidney. | |||
T30293 | Bamocaftor | VX-659 | CFTR |
Bamocaftor is a CFTR channel (DeltaF508-CFTR mutation) corrector for CF transmembrane conductance regulators designed to restore F508del-CFTR protein function. Combined use of tezacaftor and VX-561 for the treatment of c... | |||
T20341 | DNDS | CFTR | |
DNDS is a channel blocker of voltage-dependent cystic fibrosis transmembrane conductance regulator (CFTR). | |||
T29041 | UCCF-853 | UCCF853,UCCF 853 | CFTR |
UCCF-853 is a small-molecule CFTR modulator that can be used to study cystic fibrosis. | |||
T26955 | Cavosonstat | N91115,N 91115,N-91115 | GSNOR , CFTR |
Cavosonstat (N91115) is an orally active S-nitrosoglutathione reductase (GSNOR) inhibitor that promotes cystic fibrosis transmembrane conductance regulator (CFTR) maturation and plasma membrane stabilization.Cavosonstat ... | |||
T31014 | Corrector C4 | Corr 4a,Corrector C-4,Corr4a,Corrector C 4,Corr-4a | Others |
Corrector C4, a corrector commonly used to study cystic fibrosis mutants, works by alleviating the interaction between CFTR transmembrane domain mutants and protein homeostasis. | |||
T29114 | VRT-532 | CFpot-532,CFpot-532) | CFTR |
VRT-532 (CFpot-532) is an effective modulator of CFTR and is commonly used in studies of cystic fibrosis (CF) caused by CFTR defects. Arylsulfatase B (ARSB), which is necessary to reduce the accumulation of sulphate glyc... | |||
T77604 | WAY-326766 | CFTR | |
WAY-326766 increases ion transport through mutant CFTR and can be used to alter the lifespan of eukaryotes.WAY-326766 can be used to treat cystic fibrosis (CF). | |||
T36519 | Posenacaftor sodium | ||
Posenacaftor (PTI-801) sodium, a cystic fibrosis transmembrane regulator (CFTR) modulator, corrects CFTR protein folding and trafficking. It is utilized in researching cystic fibrosis (CF)[1]. | |||
T39596 | Dirocaftor | PTI-808 | |
Dirocaftor (PTI-808) is a CFTR potentiator that augments CFTR protein function via the activation of chloride channels. Dirocaftor holds potential utility for research pertaining to cystic fibrosis (CF). | |||
T78240 | (R)-Elexacaftor | (R)-VX-445 | CFTR |
(R)-Elexacaftor, an enantiomer of Elexacaftor, functions as a modulator of the cystic fibrosis transmembrane conductance regulator (CFTR). It exhibits an EC50 of 0.29 µM for the CFTR dF508 mutation [1]. | |||
T62630 | Posenacaftor | ||
Posenacaftor (PTI-801) is a cystic fibrosis transmembrane regulatory protein (CFTR) regulator. Posenacaftor corrects the folding and transport of CFTR proteins and can be used to study cystic fibrosis (CF). | |||
T25898 | Olacaftor | VX 440,VX-440,VX440 | |
Olacaftor, also known as VX-440, is a protein modulator of cystic fibrosis transmembrane regulator (CFTR). | |||
T13705 | GLPG2451 | Cysteine Protease | |
GLPG2451 is a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator. It effectively potentiates low temperature rescued F508del CFTR (EC50: 11.1 nM). | |||
T35925 | (R)-Posenacaftor sodium | ||
(R)-Posenacaftor ((R)-PTI-801) sodium, the R enantiomer of Posenacaftor, is a cystic fibrosis transmembrane regulator (CFTR) protein modulator. It corrects the folding and trafficking of the CFTR protein, and is utilized... | |||
T40386 | CP-628006 | ||
CP-628006 is a small molecule CFTR potentiator that effectively restores ATP-dependent channel gating to G551D-CFTR, the mutant form found in cystic fibrosis. | |||
T29040 | UCCF-029 | UC(CF)-029,UC(CF) 029,UCCF029,UC(CF)029 | |
UCCF-029 is an activator of cystic fibrosis transmembrane conductance regulator (CFTR). | |||
T74417 | Vanzacaftor | ||
Vanzacaftor is a cystic fibrosis transmembrane conductance regulator (CFTR) modulator researched for cystic fibrosis treatment. | |||
T13742L | Ivacaftor hydrate | VX-770 hydrate | Others |
Ivacaftor hydrate is an orally bioavailable CFTR potentiator. It also is used for cystic fibrosis treatment. | |||
T22252 | Galicaftor | Others | |
ABBV-2222 is a CFTR corrector which is studied for the treatment of cystic fibrosis (CF). | |||
T13742 | Ivacaftor benzenesulfonate | VX-770 benzenesulfonate | Others |
Ivacaftor benzenesulfonate used for cystic fibrosis treatment. is an orally bioavailable CFTR potentiator. | |||
T19788 | Piretanide | Eurelix,Tauliz,Arelix | |
Piretanide is a time- and voltage-dependent blocker of CFTR Cl(-) currents. Piretanide also acts as a loop diuretic. | |||
T27098 | Ivacaftor-D9 | deutivacaftor,CTP-656 | |
CTP-656, a cystic fibrosis transmembrane conductance regulator (CFTR) channel activator, is used potentially for the treatment of cystic fibrosis. | |||
T73827 | NJH-2-057 | ||
NJH-2-057 is an EN523 OTUB1 recruiter linked to lumacaftor, a agent used to treat cystic fibrosis that binds ΔF508-CFTR . | |||
T72860 | (R)-Olacaftor | (R)-VX-440 | |
(R)-Olacaftor ((R)-VX-440), a Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) modulator, shows promising potential in cystic fibrosis (CF) research. | |||
T39633 | Navocaftor | GLPG 3067,ABBV-3067 | |
Navocaftor, as a cystic fibrosis transmembrane regulator ( CFTR ), is a protein modulator (US 20200377491 Al, example 1). | |||
T61702 | SRI-37240 | ||
SRI-37240 is a powerful inhibitor of premature termination codons (PTCs). It effectively suppresses CFTR nonsense mutations and induces changes in cellular translation termination at PTCs in HEK293T cells. Additionally, ... | |||
T70232 | 3,4-Dephostatin | ||
3,4-Dephostatin is an inhibitor of the interactions of CFTR-associated ligand (CAL) and PSD-95/Dlg1/ZO-1 (PDZ) domain. |
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T2S1837 | Steviol | NSC 226902,Hydroxydehydrostevic acid | Others |
1. Steviol (NSC-226902), a natural sweetener, it inhibits proliferation of the gastrointestinal cancer cells intensively. 2. Steviol can induce a significant increase in CYP3A29 expression. 3. Steviol inhibits the prolif... | |||
TN1834 | Kobusin | Others , NOS , NF-κB | |
Kobusin, a Calmodulin inhibitor, shows mild antiplasmodial,anti-inflammatory, and cytotoxic activities; it may be beneficial for the treatment of neuro-inflammatory diseases through the inhibition of iNOS expression and ... |
Cat No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-03629 | Syntaxin 8 Protein, Human, Recombinant (His) | Human | HEK293 |
STX8, also known as syntaxin 8, directly interacts with HECTd3. STX8 forms the SNARE complex with syntaxin 7, vti1b and endobrevin. STX8 belongs to the syntaxin family. Members of this family are key molecules implicated... | |||
TMPH-01578 | KRT18 Protein, Human, Recombinant (His) | Human | HEK293 |
Involved in the uptake of thrombin-antithrombin complexes by hepatic cells. When phosphorylated, plays a role in filament reorganization. Involved in the delivery of mutated CFTR to the plasma membrane. Together with KRT... | |||
TMPH-01577 | KRT18 Protein, Human, Recombinant (E. coli, His) | Human | E. coli |
Involved in the uptake of thrombin-antithrombin complexes by hepatic cells. When phosphorylated, plays a role in filament reorganization. Involved in the delivery of mutated CFTR to the plasma membrane. Together with KRT... | |||
TMPY-03986 | PIST Protein, Human, Recombinant (His) | Human | E. coli |
GOPC, also known as PIST, interacts specifically with TC1 (a Rho-family small GTPase)] as a binding partner for Rhotekin. Rhotekin associates with PIST in vitro and both polarized and non-polarized MDCK (Madin-Darby cani... | |||
TMPH-01260 | AMFR Protein, Human, Recombinant (hFc) | Human | HEK293 |
E3 ubiquitin-protein ligase that mediates the polyubiquitination of lysine and cysteine residues on target proteins, such as CD3D, CYP3A4, CFTR, INSIG1, SOAT2/ACAT2 and APOB for proteasomal degradation. Component of a VC... | |||
TMPH-01259 | AMFR Protein, Human, Recombinant (His) | Human | E. coli |
E3 ubiquitin-protein ligase that mediates the polyubiquitination of lysine and cysteine residues on target proteins, such as CD3D, CYP3A4, CFTR, INSIG1, SOAT2/ACAT2 and APOB for proteasomal degradation. Component of a VC... | |||
TMPH-02478 | PRKAA1 Protein, Mouse, Recombinant (His) | Mouse | Baculovirus |
Catalytic subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism. In response to reduction of intracellular ATP levels, AMPK activat... | |||
TMPH-02479 | PRKAA1 Protein, Mouse, Recombinant (E. coli, His) | Mouse | E. coli |
Catalytic subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism. In response to reduction of intracellular ATP levels, AMPK activat... |